Sign In
Buy ANIP
$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength?
05:25am, Tuesday, 13'th Jan 2026
ANI (ANIP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
06:50am, Monday, 12'th Jan 2026
For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $873 million, $221 million to $228
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:15pm, Tuesday, 06'th Jan 2026
PRINCETON, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present
ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?
12:46pm, Tuesday, 06'th Jan 2026
ANI Pharmaceuticals' shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight momentum in rare diseases.
Will ANIP's Rare Disease Franchise Maintain Momentum in 2026?
10:56am, Friday, 02'nd Jan 2026
ANIP's rare disease push, led by Cortrophin Gel, drove 70% sales growth in the first nine months of 2025, lifting revenue outlook.
Voya Investment Management LLC Reduces Holdings in ANI Pharmaceuticals, Inc. $ANIP
05:09am, Friday, 02'nd Jan 2026
Voya Investment Management LLC lowered its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) by 54.3% during the undefined quarter, according to the company in its most recent Form 13F filin
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
10:40am, Wednesday, 31'st Dec 2025
Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
12:26pm, Sunday, 28'th Dec 2025
Oregon-based Stonepine Capital Management sold all 38,597 shares of its ANI Pharmaceuticals shares in the third quarter. The shares were worth about $2.52 million.
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Down 3.6% Following Insider Selling
01:16am, Tuesday, 23'rd Dec 2025
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP - Get Free Report)'s stock price was down 3.6% on Monday after an insider sold shares in the company. The company traded as low as $79.36 and last traded at $79
Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 22'nd Dec 2025
ANI (ANIP) could produce exceptional returns because of its solid growth attributes.
3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026
09:11am, Monday, 22'nd Dec 2025
EyePoint, ANI Pharmaceuticals and Tango Therapeutics put up a stellar show in 2025 and are set to carry the momentum in 2026 as well.
Zacks Industry Outlook Arcutis, Amicus and ANI
04:46am, Thursday, 18'th Dec 2025
Arcutis, Amicus and ANI have been highlighted in this Industry Outlook article.
5 Biotech Stocks to Watch for Potential Upside
03:21pm, Wednesday, 17'th Dec 2025
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
10:41am, Monday, 15'th Dec 2025
Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
AYAL Capital Advisors Ltd Sells 6,715 Shares of ANI Pharmaceuticals, Inc. $ANIP
03:55am, Saturday, 13'th Dec 2025
AYAL Capital Advisors Ltd lessened its position in ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) by 10.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The
